We are happy to announce that MagnaPharm and Calmino group AB have treamed up to launch PROIBS® for the treatment of symptoms related to IBS in Romania. “We are proud to announce the partnership of Calmino with MagnaPharm Romania in combined efforts to provide...
Join Us at euroPLX 84 Lisbon for Exclusive Partnering Opportunities. We are excited to announce our participation in the upcoming euroPLX 84 Lisbon, taking place on February 26-27, 2024, in Lisbon, Portugal. This event represents a significant opportunity for...
We are happy to announce that Calmino group AB and Aboutmeds (Ranua, Finland) have entered into an exclusive distribution agreement for Finland in order to launch PROIBS® for the treatment of symptoms related to IBS. Read more about PROIBS® and where to buy it in...
The PharmaSynergy conference connects global pharma professionals and showcases pharma opportunities for internationalization, in/out-licensing, investment and portfolio development. Calmino group AB will attend the conference in Berlin, 15-16th September this year....
We are happy to announce that Calmino group AB and Ewopharma (Schaffhausen, Switzerland) have entered into an exclusive distribution agreement for the territories of Czech Republic and Slovakia in order to launch PROIBS® for the treatment of symptoms related to IBS....
Recent Comments